BERTOLETTI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 560
EU - Europa 370
AS - Asia 254
OC - Oceania 1
SA - Sud America 1
Totale 1.186
Nazione #
US - Stati Uniti d'America 555
CN - Cina 248
IE - Irlanda 116
UA - Ucraina 59
FI - Finlandia 58
DE - Germania 42
IT - Italia 36
SE - Svezia 22
GB - Regno Unito 16
BE - Belgio 10
FR - Francia 7
CA - Canada 5
IN - India 2
NO - Norvegia 2
BR - Brasile 1
IQ - Iraq 1
JP - Giappone 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SG - Singapore 1
TR - Turchia 1
Totale 1.186
Città #
Chandler 127
Dublin 115
Jacksonville 90
Nanjing 64
Ashburn 59
Beijing 51
Ann Arbor 49
Nanchang 30
Pavia 24
Helsinki 21
Princeton 21
Changsha 20
Shenyang 20
Wilmington 20
Lawrence 19
Jiaxing 17
Medford 17
Hebei 15
Washington 13
Hangzhou 12
Brussels 10
Boardman 9
Tianjin 8
Woodbridge 7
Toronto 5
Verona 5
Des Moines 4
Milan 4
New York 4
Los Angeles 3
Norwalk 3
San Francisco 3
Shanghai 3
Lanzhou 2
Lucino 2
Oslo 2
Auckland 1
Changchun 1
Chicago 1
Fairfield 1
Groningen 1
Kirkuk 1
Lincoln 1
London 1
Manchester 1
Ningbo 1
Novokuznetsk 1
Portland 1
Pune 1
Singapore 1
São Paulo 1
Tokyo 1
Totale 894
Nome #
Characterisation of beta2-microglobulin conformers using Ion-Exchange LC-ESI-MS 89
Characterisation by Capillary Electrophoresis of wild type and new naturally amyloidogenic variant of beta2-microglobulin 85
Beta2-microglobulin and amyloidosis: separation and characterization of protein folding conformers 81
Integrated strategies for affinity-based screening: from binding to in silico studies 77
Characterization of different variants of beta2-microglobulin by capillary electrophoresis and high-resolution mass spectrometry 71
Capillary electrophoresis analysis of different variants of the amyloidogenic protein β2 -microglobulin as a simple tool for misfolding and stability studies 67
A Combined High Resolution Mass Spectrometric and in Silico Approach for the Characterisation of Small Ligands of β2-microglobulin 67
Capillary electrophoresis, mass spectrometry and in silico studies: a multidisciplinary approach for drug discovery 66
Evaluation of capillary electrophoresis-mass spectrometry for the analysis of the conformational heterogeneity of intact proteins using beta2-microglobulin as model compound 66
Mass spectrometry and affinity capillary electrophoresis: an integrated approach for rapid screening of protein-drug binding 63
Covalent modification of beta2-microglobulin induced by reactive carbonyl species: high resolution mass spectrometric studies 60
Integrated strategies for drug discovery: capillary electrophoresis, mass spectrometry and in silico studies 59
Capillary electrophoresis in vitro separation of Abeta oligomers as drug targets: the sample preparation issue 58
Prolidase deficiency may be reversed by hematopietic stem cell transplantation: CE analysis of dipeptides in urine and monitoring of prolidase activity in blood. 57
Advanced glycation end products of beta2-microglobulin in uremic patients as determined by high resolution mass spectrometry 56
Separation and characterisation of beta2-microglobulin folding conformers by ion-exchange liquid chromatography and ion-exchange liquid chromatography-mass spectrometry 55
Optimisation of CE-ESI-MS platform for intact protein analysis: conformational studies on beta2-microglobulin. 50
Screening of Fibrillogenesis Inhibitors of β2-microglobulin: Integrated Strategies by Mass Spectrometry, Capillary Electrophoresis and in Silico Simulations 50
Screening of fibrillogenesis inhibitors of beta2-microglobulin: integrated strategie by MS, CE and docking Studies 41
Totale 1.218
Categoria #
all - tutte 3.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020310 79 112 0 13 2 15 2 15 1 57 14 0
2020/2021138 20 11 2 15 0 15 3 19 14 22 15 2
2021/2022131 4 2 4 3 3 9 3 3 5 1 26 68
2022/2023368 31 39 1 26 38 26 0 32 140 13 17 5
2023/2024126 6 14 13 13 13 55 1 2 0 4 0 5
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 1.218